Email updates

Keep up to date with the latest news and content from Genome Biology and BioMed Central.

Research news

ATM splicing defect

Jonathan B Weitzman

Genome Biology 2002, 3:spotlight-20020314-01  doi:10.1186/gb-spotlight-20020314-01

The electronic version of this article is the complete one and can be found online at:


Published:14 March 2002

© 2002 BioMed Central Ltd

Research news

Individuals with mutations in the ATM gene develop ataxia-telangiectasia, a neurodegenrative disorder characterized by immunological defects and cancer predisposition. In an Advanced Online Publication from Nature Genetics, Pagani et al. describe a new kind of ATM mutation that leads to an unusual splicing defect (11 March 2002, DOI:10.1038/ng858). The mutant ATM allele contains a four-nucleotide deletion (GTAA) within intron 20. This deletion results in the inclusion of a 65 nucleotide 'cryptic exon' in the ATM mRNA. The ATM sequence, termed intron-splicing processing element (ISPE), is complementary to U1 snRNA. Experiments with a hybrid minigene confirmed the importance of the ISPE sequence; and interaction with U1 snRNA affected the efficiency of intron removal. Introduction of the ISPE sequence into a different genomic context, exon 9 of the cystic fibrosis transmembrane regulator (CFTR) gene, caused exon skipping and splicing defects.

References

  1. The genetic defect in ataxia-telangiectasia.

    PubMed Abstract | Publisher Full Text OpenURL

  2. [http://www.nature.com/ng/] webcite

    Nature Genetics